Cargando…
HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients
Wilms tumor (WT) is an embryonal malignant neoplasm of the kidney that accounts for 6–7% of all childhood cancers. WT seems to derive from multipotent embryonic renal stem cells that have failed to differentiate properly. Since mechanisms underlying WT tumorigenesis remain largely unknown, the aim o...
Autores principales: | Hontecillas-Prieto, Lourdes, García-Domínguez, Daniel J., García-Mejías, Rosa, Ramírez-Villar, Gema L., Sáez, Carmen, de Álava, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777772/ https://www.ncbi.nlm.nih.gov/pubmed/29383160 http://dx.doi.org/10.18632/oncotarget.23256 |
Ejemplares similares
-
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2017) -
Correction: Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2017) -
Wilms’ Tumor Blastemal Stem Cells Dedifferentiate to Propagate the Tumor Bulk
por: Shukrun, Rachel, et al.
Publicado: (2014) -
High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro
por: Wegert, Jenny, et al.
Publicado: (2019) -
Two Origins of Blastemal Progenitors Define Blastemal Regeneration of Zebrafish Lower Jaw
por: Wang, Xuelong, et al.
Publicado: (2012)